𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1150 POSTER First line chemotherapy with docetaxel plus gemcitabine in elderly or poor performance status patients with advanced non-small cell lung cancer: The experience of the hellenic oncology research group (HORG)

Book ID
122579803
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
128 KB
Volume
3
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

P.40 Oral vinorelbine and gemcitabine (o
P.40 Oral vinorelbine and gemcitabine (oVG) versus docetaxel and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis for elderly patients of a phase III randomized trial from the Hellenic Oncology Research Group (HORG)
✍ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 57 KB
Weekly docetaxel versus docetaxel/gemcit
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer : A randomized phase 3 trial of the Minnie Pearl Cancer Research Network
✍ John D. Hainsworth; David R. Spigel; Cindy Farley; Dianna L. Shipley; James D. B πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The aim of this study was to compare the efficacy of single‐agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Previously untreated pat